Table 1 Gender and age mean of patients and healthy subjects.
Gender (Male/Female) | Age – mean (Male/Female) | |
|---|---|---|
Healthy subjects | 5/5 | 41.1/42.8 |
Patients without therapy | 6/2 | 44.6/56.5 |
Patients treated with methotrexate | 7/7 | 52.8/46.6 |
Patients treated with adalimumab | 5/5 | 43.2/46.1 |